4.7 Article

Sequence specificity analysis of the SETD2 protein lysine methyltransferase and discovery of a SETD2 super-substrate

Journal

COMMUNICATIONS BIOLOGY
Volume 3, Issue 1, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s42003-020-01223-6

Keywords

-

Funding

  1. DFG [JE 252/7-4]
  2. GERLS scholarship program by the German Academic Exchange Service (DAAD) [57311832]
  3. Egyptian Ministry of Higher Education
  4. AbbVie
  5. Bayer Pharma AG
  6. Boehringer Ingelheim
  7. Canada Foundation for Innovation
  8. Eshelman Institute for Innovation
  9. Genome Canada through Ontario Genomics Institute [OGI-055]
  10. Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant] [115766]
  11. Janssen
  12. Merck KGaA, Darmstadt, Germany
  13. MSD
  14. Novartis Pharma AG
  15. Pfizer
  16. Sao Paulo Research Foundation-FAPESP
  17. Takeda
  18. Wellcome
  19. National Institute of General Medical Sciences from the National Institutes of Health [P30 GM124165]
  20. NIH-ORIP HEI grant [S10OD021527]
  21. DOE Office of Science [DE-AC02-06CH11357]
  22. Projekt DEAL

Ask authors/readers for more resources

SETD2 catalyzes methylation at lysine 36 of histone H3 and it has many disease connections. We investigated the substrate sequence specificity of SETD2 and identified nine additional peptide and one protein (FBN1) substrates. Our data showed that SETD2 strongly prefers amino acids different from those in the H3K36 sequence at several positions of its specificity profile. Based on this, we designed an optimized super-substrate containing four amino acid exchanges and show by quantitative methylation assays with SETD2 that the super-substrate peptide is methylated about 290-fold more efficiently than the H3K36 peptide. Protein methylation studies confirmed very strong SETD2 methylation of the super-substrate in vitro and in cells. We solved the structure of SETD2 with bound super-substrate peptide containing a target lysine to methionine mutation, which revealed better interactions involving three of the substituted residues. Our data illustrate that substrate sequence design can strongly increase the activity of protein lysine methyltransferases. Schuhmacher, Beldar et al. design a super-substrate peptide based on the substrate sequence specificity of the SETD2 protein lysine methyltransferase. SETD2 methylates this super-substrate 290-fold more efficiently than the original H3K36 peptide. This study illustrates that substrate sequence design can improve the activity of protein lysine methyltransferases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available